Keiretsu Capital is an investment firm that provides high-net-worth individuals, accomplished business professionals, and real estate entrepreneurs with investment opportunities in various sectors, including high-quality angel investments and blockchain technology.

Keiretsu Capital

Keiretsu Capital was established with the express mission of fostering closer ties between Keiretsu Forum angels, the institutional investor community and Keiretsu Forum portfolio companies. Keiretsu Capital provides its investors access to proprietary deal flow by investing alongside the angels, providing additional capital to complete rounds and acting to source follow on capital where appropriate. Keiretsu Capital works to increase the value of investments undertaken by Keiretsu Forum members by assisting in the successful presentation of the portfolio companies to investors including syndicate partners, venture capitalists, corporate investors, and the public markets.

Keiretsu Capital aims to provide significant capital appreciation through investment in high quality emerging companies that have been funded by the world’s largest angel investor network, Keiretsu Forum, as well as other top tier angel groups. Comprised of serious investors, accomplished business leaders and serial entrepreneurs, our mission is to accelerate technology company success and pursue the high upside value potential in these dynamic investment opportunities while promoting the sharing of risk inherent in any early stage venture.

We recognizes the crucial and active role that experienced angel investors can play in nurturing emerging companies, and draws upon the significant knowledge and expertise of our investors, Keiretsu Forum members and Keiretsu Capital managers to actively guide and support portfolio companies. 

We seek opportunities in which a strong management team is in place to guide development of the core technology and the organization needed to realize the company’s market potential. Further, we will continue to seek Keiretsu Members that bring geographic diversity to our membership to enhance the probability of identifying investment opportunities and building a broad base of contacts and functional and technical expertise. www.keiretsucapital.com

Crowd Mics

Savara Pharmaceuticals

Kineta

Alpin

Tilting Motor Works

Vispera

OtoSense

Phytelligence

Picmonic

Keiretsu Forum

Puget Sound Venture Club

#KeiretsuBacked Turn introduces a new feature on its Partner Dashboard: User Permissions. The update enhances control and flexibility by allowing tailored management of team access and roles. The latest advancement helps Turn to stand out by offering a more customized user experience compared to competitors. Learn more: https://lnkd.in/d8vqA65J

#Turn #TechInnovation #TechAdvancements #UserExperience

#KeiretsuBacked Viakoo, Inc. Earns Spot on CRN’s “10 Coolest IoT Security Companies” List. CEO Bud Broomhead said, “We are thrilled with this recognition from CRN and our expanding channel presence to better serve our customers.” This CRN recognition underscores Viakoo’s leadership and innovation in the IoT cybersecurity space, keeping it ahead of the competition. Read more: https://lnkd.in/g7B_6dUg

#Viakoo #IoTSecurity #Cybersecurity #CRNAwards #Innovation #TechLeadership #IoT

#KeiretsuBacked Joule Case has been selected as one of only 75 technologies invited to showcase at the U.S. DoD's T-REX 24-2 event, demonstrating their Quiet Tactical Power system, METEOR. "This opportunity highlights our commitment to use Joule Case technology to advance the operational readiness and effectiveness of the U.S. armed forces," said CEO James Wagoner. By providing innovative, sustainable power solutions, Joule Case is solidifying its position as a market leader in military-grade energy systems. Read more: https://ow.ly/XNtT50T2e3Q

#JouleCase #SustainableEnergy #TechnologyLeadership #EnergySolutions

#KeiretsuBacked Pattern Computer® Announces Promising In Vivo Results for Ovarian Cancer Combination Candidate. The study shows significant synergy and efficacy against human ovarian cancer xenografts in mouse models, advancing Pattern’s cutting-edge drug development. The progress highlights Pattern’s competitive edge in developing innovative cancer treatments, setting it apart in the industry. Read more: https://lnkd.in/dfJQjVsJ

#PatternComputer #OvarianCancer #CancerResearch #DrugDevelopment #CancerTreatment #Innovation #Biotech

And we are LIVE! Everyone is seated, and the opening remarks are just about to begin. Don't miss out—there's still time to join the action via Zoom! Register now and be part of this game-changing event. https://lnkd.in/dCHJ5h9p

#InvestorCapitalExpo #AngelEcosystem #InvestorCapitalExpo2024 #AngelInvesting #AngelCommunity

Last call to register for The Investor Capital Expo! Don’t miss out on meeting entrepreneurs from the most innovative early-stage companies, connecting with like-minded investors, and engaging with the best minds in the investor ecosystem. Book your place now: https://lnkd.in/dCHJ5h9p

#InvestorCapitalExpo #AngelEcosystem #InvestorCapitalExpo2024 #AngelInvesting #AngelCommunity

#KeiretsuBacked Healionics Corporation Reports Stellar 12-Month STARgraft Results with 100% Patency and Zero Infections. CTO Andrew Marshall highlights the milestone as a breakthrough, addressing a long-standing issue in vascular access. The major advancement keeps Healionics at the forefront of AV graft technology, surpassing competitors in reliability and safety. Learn more: https://ow.ly/U4Xs50SWTHP

#Healionics #STARgraft #MedicalInnovation #AVGraft #HealthcareTech

#KeiretsuBacked HaptX Inc.'s Gloves G1 won Best in Show at AWE USA 2024, receiving the Audience Award for most popular product among over 300 exhibitors and 6000 attendees. Such recognition underscores HaptX's leadership in the field, with the G1 delivering unmatched touch feedback that distinguishes it from competitors in the haptic glove market. Learn more: https://lnkd.in/dZ-uJSGX

#HaptX #AWEUSA2024 #Innovation #VirtualReality

#KeiretsuBacked 20/20 GeneSystems celebrates a major milestone with its strategic partnership with HealthLeader to introduce OneTest to Taiwan via Software as a Service (SaaS). The new alliance brings advanced multi-cancer early detection technology to the Taiwanese market and reinforces 20/20 GeneSystems' position as a market leader, providing local clinics and patients with cutting-edge cancer screening solutions. Learn more: https://lnkd.in/ds4G6xh2

#20/20GeneSystems #TaiwanHealthcare #HealthcareInnovation #SaaS #HealthTech #Biotech

Looking for the best place to discover high-growth investment opportunities? The Investor Capital Expo is where you should be.

Visionary entrepreneurs of 15 early-stage companies will take the stage at the Expo. It will be your best chance to diversify your portfolio and build the future. Register now:. Register now: https://lnkd.in/dCHJ5h9p

#InvestorCapitalExpo #AngelEcosystem #InvestorCapitalExpo2024 #AngelInvesting #AngelCommunity

news impact assignment basic	general
public peers	general	Aug 24, 2024 5:17 PM	3276d362
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Aug 24, 2024 5:17 PM	fcd08657
translate crunchbase fundingrounds	general
peers	general	Aug 24, 2024 5:17 PM	49b420d7
news basic	general	Aug 24, 2024 5:17 PM	01c2e7d9
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

KEIR

COM:KEIRETSUCAPITAL

Keiretsu Capital